Research output per year
Research output per year
Search results
-
2021
Correction to: CD16xCD33 Bispecific Killer Cell Engager (BiKE) as potential immunotherapeutic in pediatric patients with AML and biphenotypic ALL (Cancer Immunology, Immunotherapy, (2021), 70, 12, (3701-3708), 10.1007/s00262-021-03008-0)
Reusing, S. B., Vallera, D. A., Manser, A. R., Watrin, T., Bhatia, S., Felices, M., Miller, J. S., Uhrberg, M. & Babor, F., Dec 2021, In: Cancer Immunology, Immunotherapy. 70, 12, p. 3709 1 p.Research output: Contribution to journal › Comment/debate › peer-review
Open Access